Have you been diagnosed with cancer?
Do you have trouble sleeping and experience difficulty with memory, concentration, and attention?
If so - the ACTION study can help!
The ACTION study is open to individuals who have been diagnosed with cancer and have issues with their sleep and memory, concentration, and attention.
ACTION is a study conducted by researchers at Memorial University, but you do not need to live in St. John's, Newfoundland, to participate! It is entirely online and open to individuals all across Atlantic Canada (Newfoundland and Labrador, Prince Edward Island, Nova Scotia, and New Brunswick). All you need is a laptop, smart phone, or tablet. The research team is happy to help walk you through downloading any software if required.
Participating in the ACTION study involves 7 one-on-one sessions of an online insomnia treatment and participating in 5-7 research assessments. These sessions can be flexible, and the study team will work with you and your schedule for booking.
The insomnia treatment in the ACTION study is a non-medication based treatment called "Cognitive Behavior Therapy for Insomnia" (CBT-I). This treatment is designed to help address behaviors and thoughts that are known to influence the development and maintenance of sleep difficulties.
The assessments involve some questionnaires and memory tasks. The purpose of these assessments is for the researchers to understand if online treatment for insomnia can also improve memory, concentration, and attention in cancer survivors.
Department of Psychology, Memorial University, 232 Elizabeth Avenue, St. John's, Newfoundland
1. Rationale and protocol for a randomized waitlist controlled trial of videoconference delivered cognitive behaviour therapy for insomnia (CBT-I) to improve perceived cognitive impairment (PCI) among cancer survivors
Primary Investigator at Memorial University:
Sheila N. Garland, PhD
(Department of Psychology, Faculty of Science and Division of Oncology, Faculty of Medicine, MUN)
Co-Investigators:
Kara Laing, MD, FRCPC (Division of Oncology, Faculty of Medicine, MUN)
Joshua Rash, PhD, (Department of Psychology, Faculty of Science, MUN)
Melanie Seal, MD, FRCPC (Division of Oncology, Faculty of Medicine, MUN)
John Thoms, MD, FRCPC (Division of Oncology, Faculty of Medicine, MUN)
Josée Savard, PhD, (Département d'école de psychologie, Université Laval)
Veerabhadra Gadag, PhD, (Department of Biostatistics, Faculty of Medicine, MUN)
Robin Urquhart, PhD, (Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University)
Patient Co-Investigator:
Sondria Browne
Supported by a grant from the Canadian Institutes of Health Research (CIHR)